Clinical Trial Update: Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer [NA]

View source ↗

Summary

This document reports the completion of a safety study evaluating radio-labeled huA33 antibody for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• huA33 antibody (radio-labeled) (huA33)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Neoplasms, Colorectal Cancer | NA | Status: COMPLETED